Global Biosynthesis of Cannabinoids Market Growth (Status and Outlook) 2024-2030

Global Biosynthesis of Cannabinoids Market Growth (Status and Outlook) 2024-2030

According to this study, the global Biosynthesis of Cannabinoids market size will reach US$ million by 2030.

Cannabinoids are found in the cannabis plant, they can be produced in biosynthesis way. While biosynthesis has not yet proven itself as a scalable technology, it has the potential to radically alter the way cannabinoids are manufactured in the near future.These compounds are the exact same as what cannabis expresses.

This report presents a comprehensive overview, market shares, and growth opportunities of Biosynthesis of Cannabinoids market by product type, application, key players and key regions and countries.

Segmentation by product type:
THC
CBD
Others

Segmentation by Application:
Food Industry
Medical Industry
Others

This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Anandia Laboratories
Gingko Bioworks
Hyasynth Bio
InMed Pharmaceuticals
Librede
Renew Biopharma
Cronos Group
Organigram
Teewinot Life Sciences
ICC International Cannabis Corp.
Biotii Technologies Corp.
Bristol-Myers Squibb
Biogen Inc.
GW Pharmaceuticals

Please note: The report will take approximately 2 business days to prepare and deliver.